Press Releases:
July 16, 2010 Epizyme Scientists Detail Epigenetic Approaches to Cancer Therapy in Drug Discovery Today: Therapeutic Strategies and Current Opinion in Chemical Biology
May 21, 2010 Transforming Cancer Therapy via HMT Inhibition, MSA Partners, Japan (English)
Transforming Cancer Therapy via HMT Inhibition, MSA Partners, Japan (Japanese)
May 14, 2010 Epizyme Appoints Mikel Moyer, Ph.D., Vice President of Molecular Discovery
March 24, 2010 Epizyme Expands Leadership Team, Appointing Robert Gould, Ph.D. as CEO and Jason Rhodes as EVP and CBO
December 8, 2009 Epizyme Closes $40M Series B Financing NEA Joins Syndicate; NEA's David Mott Joins Board
October 23, 2009 Epizyme Appoints Hoyoung Huh, MD, Ph.D., Chairman of the Board of Directors
October 7, 2009 Epizyme Closes $32 Million Series B Financing, Led By New Investor Bay City Capital
September 9, 2009 Nature Reviews Drug Discovery Publishes Epizyme-authored Paper on Protein Methyltransferases
In Print: Epizyme featured by BusinessWeek as one of the most innovative new start-ups